EN | UA
EN | UA

Help Support

Back

ACTH and oral steroids found superior to nonstandard therapies for infantile spasms

ACTH and oral steroids found superior to nonstandard therapies for infantile spasms ACTH and oral steroids found superior to nonstandard therapies for infantile spasms
ACTH and oral steroids found superior to nonstandard therapies for infantile spasms ACTH and oral steroids found superior to nonstandard therapies for infantile spasms

What's new?

For the initial management of infantile spasms, ACTH and oral steroids are superior in comparison with non-standard therapy.

A study published in Neurology offered Class III evidence that for children with newly onset infantile spasms, adrenocorticotropic hormone (ACTH) or oral steroids have superior efficacy when compared to non-standard therapies. Researchers aimed to investigate the efficacy of initial therapy for infantile spasms that initiated at age 2-24 months in children.

Children with novel onset infantile spasms were prospectively followed by the National Infantile Spasms Consortium. Freedom from therapy failure at sixty days needed no 2nd  therapy for infantile spasms and no clinical spasms following thirty days of therapy initiation. With the aid of within-center correlation with generalized estimating equations and propensity score weighting, management of therapeutic selection bias was done. The freedom from treatment failure rates is shown in Table 1:


The alteration from oral steroids to ACTH was not estimated to impact response (noted 44% estimated to alter to 44%). The alteration from the non-standard treatment to ACTH would enhance response from 8% to 39%, and to oral steroids from 8% to 38%. Notably, large but not profound estimated effects of altering from vigabatrin to ACTH (29% to 42%), vigabatrin to oral steroids (29% to 42%), and non-standard treatment to vigabatrin (8% to 20%) were witnessed.

Considering children managed with vigabatrin, children suffering from tuberous sclerosis complex responded more frequently when compared to others (62% vs 29%). The estimated efficacy of vigabatrin is between non-standard treatment and ACTH / oral steroids, despite the fact that the study sample was underpowered for statistical confidence. When utilized, vigabatrin worked best for the tuberous sclerosis complex.

Source:

Neurology

Article:

Comparative Effectiveness of Initial Treatment for Infantile Spasms in a Contemporary US Cohort

Authors:

Zachary M. Grinspan et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: